Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis.

Leyh, Catherine; Ehmer, Ursula; Roessler, Daniel; Philipp, Alexander B; Reiter, Florian P; Jeliazkova, Petia; Jochheim, Leonie S; Jeschke, Matthias; Hammig, Janina; Ludwig, Johannes M; Theysohn, Jens M; Geier, Andreas; Lange, Christian M.

Afiliación

Leyh C; Department for Gastroenterology and Hepatology, University Duisburg-Essen, 45141 Essen, Germany.
Ehmer U; Department of Internal Medicine II, Klinikum Rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Roessler D; Department of Internal Medicine II, LMU University Hospital Munich, 81377 Munich, Germany.
Philipp AB; Department of Internal Medicine II, LMU University Hospital Munich, 81377 Munich, Germany.
Reiter FP; Department of Medicine II, Division of Hepatology, University Hospital Würzburg, 97080 Würzburg, Germany.
Jeliazkova P; Department of Internal Medicine II, Klinikum Rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Jochheim LS; Department for Gastroenterology and Hepatology, University Duisburg-Essen, 45141 Essen, Germany.
Jeschke M; Department for Gastroenterology and Hepatology, University Duisburg-Essen, 45141 Essen, Germany.
Hammig J; Department for Gastroenterology and Hepatology, University Duisburg-Essen, 45141 Essen, Germany.
Ludwig JM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Duisburg-Essen, 45141 Essen, Germany.
Theysohn JM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Duisburg-Essen, 45141 Essen, Germany.
Geier A; Department of Medicine II, Division of Hepatology, University Hospital Würzburg, 97080 Würzburg, Germany.
Lange CM; Department for Gastroenterology and Hepatology, University Duisburg-Essen, 45141 Essen, Germany.